OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Novel classes of immunotherapy for breast cancer.
Published in:
Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 15, doi. 10.1007/s10549-021-06405-2
By:
- Hernando-Calvo, Alberto;
- Cescon, David W.;
- Bedard, Philippe L.
Publication type:
Article
Homologous Recombination Deficiency (HRD) as a Potential Pan-Cancer Biomarker for PARP Inhibition.
Published in:
Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 241, doi. 10.36401/JIPO-24-X2
By:
- Hernando-Calvo, Alberto;
- Romero, Paula;
- Saavedra, Omar;
- Catalogne, Francesca;
- Oberoi, Arjun;
- Alonso, Guzman;
- Mirallas, Oriol;
- Vieito, Maria;
- Braña, Irene;
- Lostes, Julia;
- Galvão, Vladimir;
- Pretelli, Giulia;
- Ortega, Belen;
- Aguilar, Susana;
- Dienstmann, Rodrigo;
- Garralda, Elena;
- Vivancos, Ana;
- Serrano, César
Publication type:
Article
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS‐001 clinical trial.
Published in:
Cancer Medicine, 2023, v. 12, n. 20, p. 20299, doi. 10.1002/cam4.6589
By:
- Hernando‐Calvo, Alberto;
- Malone, Eoghan;
- Day, Daphne;
- Prawira, Amy;
- Weinreb, Ilan;
- Yang, S. Y. Cindy;
- Wong, Horace;
- Rodriguez, Angela;
- Jennings, Sarah;
- Eliason, Anneli;
- Wang, Lisa;
- Spreafico, Anna;
- Siu, Lillian L.;
- Hansen, Aaron R.
Publication type:
Article